These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31008686)

  • 1. PPAR-δ Activation Ameliorates Diabetes-Induced Cognitive Dysfunction by Modulating Integrin-linked Kinase and AMPA Receptor Function.
    Abdel-Rahman EA; Bhattacharya S; Buabeid M; Majrashi M; Bloemer J; Tao YX; Dhanasekaran M; Escobar M; Amin R; Suppiramaniam V
    J Am Coll Nutr; 2019; 38(8):693-702. PubMed ID: 31008686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
    Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
    Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PPARδ agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation.
    Schnegg CI; Greene-Schloesser D; Kooshki M; Payne VS; Hsu FC; Robbins ME
    Free Radic Biol Med; 2013 Aug; 61():1-9. PubMed ID: 23499837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice.
    An YQ; Zhang CT; Du Y; Zhang M; Tang SS; Hu M; Long Y; Sun HB; Hong H
    Metab Brain Dis; 2016 Jun; 31(3):663-71. PubMed ID: 26864581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism.
    Lee MY; Choi R; Kim HM; Cho EJ; Kim BH; Choi YS; Naowaboot J; Lee EY; Yang YC; Shin JY; Shin YG; Chung CH
    Exp Mol Med; 2012 Oct; 44(10):578-85. PubMed ID: 22824914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury.
    Paterniti I; Esposito E; Mazzon E; Galuppo M; Di Paola R; Bramanti P; Kapoor A; Thiemermann C; Cuzzocrea S
    J Pharmacol Exp Ther; 2010 May; 333(2):465-77. PubMed ID: 20176685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of PPARγ Ameliorates Spatial Cognitive Deficits through Restoring Expression of AMPA Receptors in Seipin Knock-Out Mice.
    Zhou L; Chen T; Li G; Wu C; Wang C; Li L; Sha S; Chen L; Liu G; Chen L
    J Neurosci; 2016 Jan; 36(4):1242-53. PubMed ID: 26818512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PPAR-β/δ Attenuates Brain Injury by Suppressing Inflammation and Apoptosis in a Collagenase-Induced Intracerebral Hemorrhage Mouse Model.
    Tang X; Yan K; Wang Y; Wang Y; Chen H; Xu J; Lu Y; Wang X; Liang J; Zhang X
    Neurochem Res; 2020 Apr; 45(4):837-850. PubMed ID: 31939088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression.
    Kariharan T; Nanayakkara G; Parameshwaran K; Bagasrawala I; Ahuja M; Abdel-Rahman E; Amin AT; Dhanasekaran M; Suppiramaniam V; Amin RH
    Neurobiol Aging; 2015 Mar; 36(3):1451-61. PubMed ID: 25510319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.
    Kapoor A; Shintani Y; Collino M; Osuchowski MF; Busch D; Patel NS; Sepodes B; Castiglia S; Fantozzi R; Bishop-Bailey D; Mota-Filipe H; Yaqoob MM; Suzuki K; Bahrami S; Desvergne B; Mitchell JA; Thiemermann C
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1506-15. PubMed ID: 20693380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.
    Toral M; Gómez-Guzmán M; Jiménez R; Romero M; Zarzuelo MJ; Utrilla MP; Hermenegildo C; Cogolludo Á; Pérez-Vizcaíno F; Gálvez J; Duarte J
    J Hypertens; 2015 Sep; 33(9):1831-44. PubMed ID: 26147382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.
    Niu HS; Ku PM; Niu CS; Cheng JT; Lee KS
    Drug Des Devel Ther; 2015; 9():5625-32. PubMed ID: 26508837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats.
    Yue TL; Nerurkar SS; Bao W; Jucker BM; Sarov-Blat L; Steplewski K; Ohlstein EH; Willette RN
    J Pharmacol Exp Ther; 2008 May; 325(2):466-74. PubMed ID: 18287212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease.
    Du Y; Fu M; Huang Z; Tian X; Li J; Pang Y; Song W; Tian Wang Y; Dong Z
    Aging Cell; 2020 Mar; 19(3):e13113. PubMed ID: 32061032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.
    Capozzi ME; McCollum GW; Savage SR; Penn JS
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4197-207. PubMed ID: 23716627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR-β/δ activation promotes phospholipid transfer protein expression.
    Chehaibi K; Cedó L; Metso J; Palomer X; Santos D; Quesada H; Naceur Slimane M; Wahli W; Julve J; Vázquez-Carrera M; Jauhiainen M; Blanco-Vaca F; Escolà-Gil JC
    Biochem Pharmacol; 2015 Mar; 94(2):101-8. PubMed ID: 25662586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of PPAR-β/δ/miR-17/TXNIP pathway in neuronal apoptosis after neonatal hypoxic-ischemic injury in rats.
    Gamdzyk M; Doycheva DM; Malaguit J; Enkhjargal B; Tang J; Zhang JH
    Neuropharmacology; 2018 Sep; 140():150-161. PubMed ID: 30086290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PPAR-β/δ agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease.
    Das NR; Gangwal RP; Damre MV; Sangamwar AT; Sharma SS
    Curr Neurovasc Res; 2014 May; 11(2):114-24. PubMed ID: 24635117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema.
    Ozawa C; Horiguchi M; Akita T; Oiso Y; Abe K; Motomura T; Yamashita C
    Biol Pharm Bull; 2016; 39(5):778-85. PubMed ID: 27150147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
    Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.